Matthias Hauer, Parliamentary State Secretary to the Federal Minister for Research, Technology and Area (BMFTR): “With the High-Tech Program for Germany, we are enhancing competitiveness, value creation, and sovereignty through research study and innovation– especially in the biotechnology and pharmaceutical markets. The objective is to bring research findings into useful application quicker and to reinforce ingenious companies, consisting of those in the health care sector, in Germany. The BMFTR’s VIP+ program for recognition funding makes it possible for exceptional research study to lead to concrete applications and– anywhere possible– economic worth production and societal advantages. The VIP+ moneyed job MediMikroPart, with its ingenious melt electrostatic precipitator, will make an essential contribution to the pharmaceutical industry, to Germany as a center for research and development, and eventually to a high-performing and effective health care system. I wish the task team every success.”
For the body to take in a drug as effectively as possible, its active ingredient must liquify quickly in water. It is exactly this prerequisite, nevertheless, that is frequently a challenge. The new melt electrostatic precipitator can be used to embed drug particles uniformly and gently in a carrier matrix of excipients. This provider matrix acts as a “practical environment” that enables the active ingredient to better release its result in the body, yet without altering its chemical structure. To attain this, the drug particles are first produced by spray drying and then transferred to the melt electrostatic precipitator, where they are deposited in a melt that works as a matrix after solidification. In addition, a brand-new type of aerosol generator helps to produce particularly great particles in the low micrometer range.
Pharmaceuticals, food innovation or plant security
“With our procedure, we have already observed a significant enhancement in the dissolution habits of improperly water-soluble active ingredients. We are happy that we will now be able– thanks to the validation financing– to additional develop the innovation,” says Prof. Thommes, who has headed the Chair of Solids Process Engineering at the Department of Biochemical and Chemical Engineering considering that 2014. In the first circumstances, the brand-new process is intended for pharmaceutical applications, however it can also be used in food technology or plant protection.
PROvendis GmbH signed up the copyright rights on behalf of TU Dortmund University. The patent was granted in the United States in May 2025, and the innovation is also protected in Europe. “As we go into the marketplace, we are seeing that our broad portfolio of copyright rights is a crucial element for the successful acquisition of financing,” states Teacher Thommes. His melt electrostatic precipitator had actually currently achieved success in the local financing competitors “NRW Patent Recognition,” getting an initial EUR200,000 to additional advance the innovation’s maturity.